LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas
2017 · The American Journal of Surgical Pathology · 28 citations
https://doi.org/10.1097/pas.0000000000000839
L
Luís Colomo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
5.2K
Citations
31
h-index
48
i10-index
Luís Colomo is an academic researcher from Universitat Pompeu Fabra. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & Chronic Lymphocytic Leukemia Research. The author has an h-index of 31, co-authored 103 publications.
ORCID: 0000-0001-5236-5085Papers by this author
worksClinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas
2020 · Cancers · 16 citations
https://doi.org/10.3390/cancers12040884
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas
2021 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 5 citations
https://doi.org/10.1007/s00428-021-03091-9
Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome
2021 · Thrombosis Research · 4 citations
https://doi.org/10.1016/j.thromres.2021.02.021
A-258 JAK2 rearrangements in indolent CD8+ cytotoxic mycosis fungoides
2024 · European Journal of Cancer · 0 citations
https://doi.org/10.1016/j.ejca.2024.114354
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat